• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Veracyte Inc (NQ: VCYT )

    38.71 -0.82 (-2.07%)
    Streaming Delayed Price Updated: 12:11 PM EST, Nov 14, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Veracyte Inc

    < Previous 1 2 3 4 Next >
    Smaller Cap Biotechs Are In Season: How Are We Doing?
    SMID biotech stocks still see a lot of speculative interest except for a brief sell-off on August 5 when the XBI touched $91.The XBI is near its 2024 high in the $103 range. 
    Via Talk Markets
    Breaking Down Veracyte: 4 Analysts Share Their Views
    Via Benzinga
    Tempus AI Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
    A Relative Strength Rating upgrade for Tempus AI shows improving technical performance. 
    Via Investor's Business Daily
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Thermo Fisher Scientific Stock Sees RS Rating Jump To 81
    Thermo Fisher Scientific stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, rising from 77 to 81. 
    Via Investor's Business Daily
    Lumen Tech & Upstart Are Among Top 7 Mid Cap Gainers Last Week (Aug 4-Aug 10): Are The Others In Your Portfolio?
    Lumen, Upstart, ADMA, Sweetgreen, Veracyte, Clear Secure, and Core Scientific were best performers last week. Did you invest in them? 
    Via Benzinga
    A Glimpse Into The Expert Outlook On Veracyte Through 4 Analysts
    Via Benzinga
    Recap: Veracyte Q4 Earnings
    Via Benzinga
    Earnings Outlook For Veracyte
    Via Benzinga
    Diagnostic Tests Maker Veracyte's Q2 Is 'All-Around Very Good Quarter': Analysts Maintain Bullish View
    Veracyte reports Q2 sales of $114.43M, a 27% increase year over year, surpassing the $100.3 million consensus. Testing revenue rose 31% to $107 million, driven by strong performance of Decipher... 
    Via Benzinga
    Shopify Posts Upbeat Earnings, Joins Axon Enterprise, Aspen Technology, Illumina, Global Payments And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Pre-market stock movers are a hot topic on Wednesday and we have all of the latest news traders need to know about them this morning! 
    Via InvestorPlace
    Veracyte: Q3 Earnings Insights
    Via Benzinga
    The Latest Analyst Ratings for Veracyte
    Via Benzinga
    VCYT Stock Earnings: Veracyte Beats EPS, Beats Revenue for Q2 2024
    VCYT stock results show that Veracyte beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    The 3 Best Personalized Nutrition Stocks to Buy Now
    Explore personalized nutrition stocks capitalizing on AI, machine learning and genetic profiling to provide targeted dietary solutions. 
    Via InvestorPlace
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Trading SMID Biotech Stocks In A Volatile Market
    Trading SMID biotech stocks is difficult no matter what you know. Large cap biopharma with dividends should be the focus for non-traders. Healthcare and smaller caps are lagging within the context of a... 
    Via Talk Markets
    Cathie Wood-Lead Ark Invest Dumps $7.6M Worth Of Robinhood Shares Amid GameStop Buzz, Bitcoin Choppiness
    On Monday, Cathie Wood-led Ark Invest made a significant move by reducing its holdings in Robinhood Markets Inc (NASDAQ:HOOD). This decision came amidst a period of market fluctuations and followed a... 
    Via Benzinga
    VCYT Stock Earnings: Veracyte Beats EPS, Beats Revenue for Q1 2024
    VCYT stock results show that Veracyte beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
    Via InvestorPlace
    Cathie Wood's Ark Invest Dumps $17M In Coinbase Shares As The Exchange Grappled With Disruption Amid Bitcoin Rally
    On Wednesday, Cathie Wood-led Ark Invest made a significant move by selling over $17 million worth of Coinbase Global Inc (NASDAQ:COIN) shares. 
    Via Benzinga
    Cathie Wood's Ark Invest Sheds $9.3M Worth Of Coinbase Shares Amid Bitcoin Rally — Robinhood Stock Also Sold
    On Tuesday, Cathie Wood-led Ark Invest adjusted its portfolio, making significant trades. 
    Via Benzinga
    Cathie Wood's Ark Invest Offloads $6.9M Worth of Coinbase, Robinhood Shares Each Amid Searing Bitcoin Rally — Nvidia Stock Also Shed
    On Monday, Cathie Wood-led Ark Invest adjusted its portfolio, notably selling shares of cryptocurrency-related companies such as Robinhood Markets Inc (NASDAQ:HOOD) and Coinbase Global Inc (NASDAQ: 
    Via Benzinga
    7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff
    Although the health innovation space can be a risky environment, undervalued biotech stocks can take some of the edge off. 
    Via InvestorPlace
    Cathie Wood's Ark Invest Buys Over $92M Worth Of ProShares Bitcoin ETF, Sells Coinbase, Block And Palantir Shares
    On Wednesday, Cathie Wood-led Ark Invest made a significant move in the cryptocurrency space, purchasing over $92 million worth of ProShares Bitcoin Strategy ETF (NYSE:BITO). 
    Via Benzinga
    Topics ETFs
    Are You A Trader Or Investor: Biotech Momentum Is Picking Up
    ETFs have not helped as portfolio fillers but they can identify trends. We should play this rally out of a biotech bear market. 
    Via Talk Markets
    Topics ETFs
    7 Undervalued Stocks That Analysts Love Right Now
    With many investors concerned about what may lie ahead in the market, these potentially de-risked undervalued stocks may be ideal. 
    Via InvestorPlace
    Earnings Scheduled For February 22, 2024
    Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on revenue of $260.00 million. 
    Via Benzinga
    Earnings Scheduled For November 7, 2023
    Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter. 
    Via Benzinga
    Veracyte Stock Is Volatile After-Hours - Here's Why
    Veracyte, Inc. (NASDAQ: VCYT) shares are volatile after-hours on Wednesday after the company announced that new data from a phase 3 trial validates the value of the Decipher Prostate Genomic Classifier... 
    Via Benzinga
    Is This Underfollowed Genetic Diagnostics Stock a Buy for Growth Investors?
    The genetic test maker is rapidly increasing test volumes. 
    Via The Motley Fool
    Looking for Biotech AI Stocks? 3 Names That Will Benefit From the AI Boom
    AI is changing the face of biotechnology and drug discovery. Don't miss out on the next big boom in biotech, here are 3 stocks to consider. 
    Via InvestorPlace
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.